Jennifer L. Kuntz

Jennifer L. Kuntz

Auto-generated profile, based on publicly available information

Jennifer L. Kuntz

Kaiser Permanente Center for Health Research , Portland, Oregon

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2011 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JKJennifer L Kuntz
Jennifer L Kuntz
ECElizabeth Chrischilles
Elizabeth Chrischilles
JPJane F Pendergast
Jane F Pendergast
LHLoreen A Herwaldt
Loreen A Herwaldt
PPPhilip M Polgreen
Philip M Polgreen
Clostridium difficile is the most common cause of nosocomial infectious diarrhea in the United States. However, recent reports have documented that C. difficile infections (CDIs) are occurring among patients without traditional risk factors. The purpose of this study was to examine the epidemiology of CA-CDI, by estimating the incidence of CA-CDI and HA-CDI, identifying patient-related risk factors for CA-CDI, and describing adverse health outcomes of CA-CDI.

1 December 2014 in Patient Education and Counseling
Verified
Journal Article
Closed access
JKJennifer L. Kuntz
Jennifer L. Kuntz
MSMonika M. Safford
Monika M. Safford
JSJasvinder Singh
Jasvinder Singh
SPShobha Phansalkar
Shobha Phansalkar
SSSarah P. Slight
Sarah P. Slight
MHMark C. Hornbrook
Mark C. Hornbrook

1 June 2021 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
JKJennifer L. Kuntz
Jennifer L. Kuntz
DYDeborah R. Young
Deborah R. Young
BSBrian E. Saelens
Brian E. Saelens
LFLawrence D. Frank
Lawrence D. Frank
RMRichard T. Meenan
Richard T. Meenan
SFStephen P. Fortmann
Stephen P. Fortmann

1 June 2018 in The Permanente Journal
Verified
Journal Article
Closed access
JKJennifer Kuntz
Jennifer Kuntz
LKLouis Kouch
Louis Kouch
DCDaniel Christian
Daniel Christian
PPPreston L Peterson
Preston L Peterson
IGInga Gruss
Inga Gruss
Jennifer Kuntz, PhD; Louis Kouch, PharmD; Daniel Christian, PharmD; Preston...

1 October 2012 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
JKJennifer L. Kuntz
Jennifer L. Kuntz
EJEric S. Johnson
Eric S. Johnson
MRMarsha A. Raebel
Marsha A. Raebel
APAmanda F. Petrik
Amanda F. Petrik
XYXiuhai Yang
Xiuhai Yang
DSDavid H. Smith
David H. Smith
Objective.: To describe the epidemiology and healthcare costs of Clostridium difficile infection (CDI) identified in the outpatient setting.Design.: Population-based, retrospective cohort study.Patients.: Kaiser Permanente Colorado and Kaiser Permanente Northwest members between June 1, 2005, and September 30, 2008.Methods.: We identified persons with incident CDI and classified CDI by whether it was identified in the outpatient or inpatient healthcare setting. We collected information about baseline variables and follow-up healthcare utilization, costs, and outcomes among patients with CDI. We compared characteristics of patients with CDI identified in the outpatient versus inpatient setting.Results.: We identified 3,067 incident CDIs; 56% were identified in the outpatient setting. Few strong, independent predictors of diagnostic setting were identified, although a previous stay in a nonacute healthcare institution (odds ratio [OR], 1.45 [95% confidence interval (CI), 1.13-1.86]) was statistically associated with outpatient-identified CDI, as was age from 50 to 59 years (OR, 1.64 [95% CI, 1.18-2.29]), 60 to 69 years (OR, 1.37 [95% CI, 1.03-1.82]), and 70 to 79 years (OR, 1.36 [95% CI, 1.06-1.74]), when compared with persons aged 80-89 years.Conclusions.: We found that more than one-half of incident CDIs in this population were identified in the outpatient setting. Patients with outpatient-identified CDI were younger with fewer comorbidities, although they frequently had previous exposure to healthcare. These data suggest that practitioners should be aware of CDI and obtain appropriate diagnostic testing on outpatients with CDI symptoms.Infect Control Hosp Epidemiol 2012;33(10):1031-1038

21 January 2021 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
JKJennifer L. Kuntz
Jennifer L. Kuntz
JDJohn F. Dickerson
John F. Dickerson
JSJennifer L. Schneider
Jennifer L. Schneider
AFAlison J. Firemark
Alison J. Firemark
DPDea Papajorgji-Taylor
Dea Papajorgji-Taylor
DSDavid H. Smith
David H. Smith